Everyday Health

Group Black Launches She's Good [For Real], A First-of-Its-Kind Platform Centered Around Black Women's Health

Retrieved on: 
Wednesday, April 17, 2024
Pain, Real, MBE, Learning, Everyday Health, NIH, Woman, CDC, Health, NAACP Image Awards, Partnership, Pew, Life, Black, Pew Research Center, Senior, Editorial, Mother, Good, Community, Organization, Nursing

NEW YORK, April 17, 2024 /PRNewswire/ -- Today, in conjunction with Black Maternal Health Week, Group Black, an MBE-certified media company, announced the launch of She's Good [For Real] -- a first-of-its-kind digital platform designed to empower Black women to better advocate for their health and the health of their families. 

Key Points: 
  • She's Good [For Real] will become a premier destination within Everyday Health, building off the award-winning success of their Black Health Facts destination, taking and transforming that platform to all new levels.
  • As a part of her collaboration with She's Good [For Real], Group Black will support Baby Yams, Tatyana's first venture in the retail space.
  • "This is why I am so eager to partner with Group Black to help bring She's Good [For Real] to life.
  • "As Black women, we bravely proclaim 'I'm good' when asked how we're doing - giving the impression we're virtually indestructible," said Ashley Banks, Senior Vice President, Group Black.

RS BioTherapeutics Promotes Michelle L. Shuffett, MD to Chief Medical Officer

Retrieved on: 
Tuesday, October 31, 2023
Knowledge, University, Children's Hospital Los Angeles, London, Medicine, Barts and The London School of Medicine and Dentistry, Born This Way Foundation, MD, TEC, Bureau of Oceans and International Environmental and Scientific Affairs, Organization, Health, Research, IPF, Senior, RS, Boehringer Ingelheim, Everyday Health, Idiopathic disease, UCLA Mattel Children's Hospital, NIH, Patient, Hospital, COPD, Idiopathic pulmonary fibrosis, Child, Pharmaceutical industry, Nursing, Economics

CUMBERLAND, Md., Oct. 31, 2023 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to develop life-changing medicines for the millions of people suffering from diseases characterized by pulmonary inflammation, is pleased to announce that it has appointed Michelle L. Shuffett, MD as its Chief Medical Officer.

Key Points: 
  • CUMBERLAND, Md., Oct. 31, 2023 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to develop life-changing medicines for the millions of people suffering from diseases characterized by pulmonary inflammation, is pleased to announce that it has appointed Michelle L. Shuffett, MD as its Chief Medical Officer.
  • Commenting on the promotion of Dr. Shuffett to Chief Medical Officer, Dean Hart, Chief Executive Officer of RS BioTherapeutics said, “Michelle has been a tremendous addition to our leadership team.
  • Michelle will Chair the TEC and that group will help guide the development of RSBT-001.”
    Commenting on her appointment, Dr. Shuffett said, “I’m thrilled to continue working with the incredible leadership team at RS BioTherapeutics in this new role.
  • Dr. Shuffett has also served in senior roles at several organizations including Synapse Medical Communications, Everyday Health, Columbia Care, and Radicle Science.

RS BioTherapeutics Appoints Michelle L. Shuffett, MD as SVP of Medical and Scientific Affairs

Retrieved on: 
Monday, June 5, 2023
Children's Hospital Los Angeles, COPD, Medicine, Born This Way Foundation, University, Senior, Bureau of Oceans and International Environmental and Scientific Affairs, London, Health, Cannabinoid, Research, Child, Boehringer Ingelheim, Organization, Science, UCLA Mattel Children's Hospital, MD, Patient, RS, Hospital, Everyday Health, Rest, London School of Medicine for Women, Management, Nursing, Economics

Dr. Shuffett attended medical school at the University of Kentucky, completed her residency at UCLA Mattel Children's Hospital, and practiced at Children's Hospital Los Angeles.

Key Points: 
  • Dr. Shuffett attended medical school at the University of Kentucky, completed her residency at UCLA Mattel Children's Hospital, and practiced at Children's Hospital Los Angeles.
  • She began her career in the pharmaceutical industry at Boehringer Ingelheim, focusing on COPD opinion leader development and advocacy, medical marketing communications, research, and medical-legal review.
  • During that time, she also attended the London School of Economics and earned certifications in Healthcare Economics and Quantitative Analysis.
  • Commenting on the appointment of Dr. Shuffett, Dean Hart, Chief Executive Officer of RS BioTherapeutics said, “We are very pleased to welcome Michelle as Senior Vice President of Medical and Scientific Affairs.

Aravive Appoints Carolina Petrini as Chief Commercial Officer

Retrieved on: 
Tuesday, April 11, 2023
Endocrinology, Employment, Central nervous system, Therapy, Senior, Marketing, Health care, Option, Health, DABT, Sale, PROC, Fast-moving consumer goods, Dermatology, Fortune 500, Patient, Everyday Health, Rare, George Washington University, Pharmaceutical industry

HOUSTON, April 11, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced the appointment of Carolina Petrini as the Company’s new Chief Commercial Officer effective April 10, 2023.

Key Points: 
  • HOUSTON, April 11, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced the appointment of Carolina Petrini as the Company’s new Chief Commercial Officer effective April 10, 2023.
  • Ms. Petrini brings over two decades of experience in developing pre-commercial, launch readiness and commercial strategies, building and leading high-performing commercial teams.
  • “We are delighted to welcome Carolina as our new Chief Commercial Officer,” said Gail McIntyre, Ph.D., DABT, Chief Executive Officer of Aravive.
  • We look forward to leveraging her expertise as we prepare for the upcoming Phase 3 data readout in platinum-resistant ovarian cancer (PROC) in mid-2023.”
    Ms. Petrini commented, “I am thrilled to join the Aravive team and build the commercial organization.

Aditxt Names Media Industry Veteran Maureen Connolly as Chief Content and Engagement Officer

Retrieved on: 
Wednesday, March 8, 2023
Marketing, Health, Communications, Genetics, Other Health, Content Marketing, Biotechnology, Everyday Health, Life, Science, Connolly, Communication, The Quarto Group, NPR, Patient, COVID-19, Immune system, Condé Nast, African American Engagement Office, Mental health, PBS, Time Inc., Random House, Book, Management

Aditxt, Inc. , (NASDAQ: ADTX) (“Aditxt” or the “Company”), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, is pleased to announce Maureen Connolly has joined Aditxt as Chief Content and Engagement Officer.

Key Points: 
  • Aditxt, Inc. , (NASDAQ: ADTX) (“Aditxt” or the “Company”), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, is pleased to announce Maureen Connolly has joined Aditxt as Chief Content and Engagement Officer.
  • Connolly is an award-winning content strategist and audience builder with 25+ years of experience in the health, science, wellness, technology, and chronic conditions space.
  • “Maureen’s background, experience and passion couldn’t be better fit for this role,” said Amro Albanna, co-founder, chairman, and CEO of Aditxt.
  • “Aditxt believes in radically transparent communication and engagement across the board — with patients, shareholders, Wall Street, doctors and employees.

Consumer Biotech Company Tally Health™ Launches Platform Aimed at Extending Longevity

Retrieved on: 
Thursday, February 23, 2023
Tissue, Everyday Health, Mouse, DNA, Vitality, Health, Longevity, Cell, Ageing, Research, Genetics, Reading, How I Braved Anu Aunty and Co-Founded a Million Dollar Company, Environment, Habit, Human, Epigenome, Tally, Science, L Catterton, IPO, Data, Dietary supplement

NEW YORK, Feb. 23, 2023 /PRNewswire/ -- Tally Health™, a revolutionary consumer-facing biotechnology company founded to change the way we age, launches today. Co-Founded by Dr. David Sinclair, one of the world's foremost experts on aging and human longevity, Tally Health develops proprietary, science-backed technology aimed at improving healthspan and extending longevity at the cellular level.

Key Points: 
  • Co-Founded by Dr. David Sinclair, one of the world's foremost experts on aging and human longevity, Tally Health develops proprietary, science-backed technology aimed at improving healthspan and extending longevity at the cellular level.
  • "Our genetics determines less than 10% of our longevity; more than 90% is a result of our daily lifestyle choices."
  • Consumer interest in the longevity space has exploded, with the global longevity economy projected to reach $27 trillion in 2026 and the AgeTech segment reaching $2.7 trillion by 2025 (Source: Longevity Technology).
  • "We built Tally to be the science-backed, health ally for anyone looking to improve their healthspan and increase longevity," said Goldey.

Intertrust MarketMaker™ Solutions Toolkit to Speed Transition to Web 3.0 for the Creator Economy

Retrieved on: 
Wednesday, January 25, 2023
Software, Internet, Audio, Video, Data Management, Consumer Electronics, Technology, Other Technology, Security, Marlin (DRM), Television, TRM, Trust, Non-fungible token, DRM, Fellow, Web 3.0, Microsoft, Blockchain, Everyday Health, NFT, Intertrust, Roadstead, Cryptocurrency, Apple

Intertrust , the world’s leading trusted distributed computing and rights management provider, today announced Intertrust MarketMaker ™, a Web 3.0 solutions toolkit that enables media service providers, network operators and NFT marketplace operators to easily adopt trusted and advanced content distribution models.

Key Points: 
  • Intertrust , the world’s leading trusted distributed computing and rights management provider, today announced Intertrust MarketMaker ™, a Web 3.0 solutions toolkit that enables media service providers, network operators and NFT marketplace operators to easily adopt trusted and advanced content distribution models.
  • The Intertrust MarketMaker Solutions Toolkit offers a single developer platform with end-to-end media protection and rights management that provides creators, distributors and device makers with a consistent level of trust and security to manage their assets.
  • Developers can use MarketMaker to integrate their products with preferred license management systems, including third-party blockchain-based technologies and traditional cloud-based systems.
  • ExpressPlay is the world’s richest and most deployed DRM platform, supporting DRM technologies from Apple, Google, Microsoft and the open-standards based Marlin DRM.

Castle Connolly Releases Castle Connolly Top Doctors 2023

Retrieved on: 
Tuesday, January 24, 2023
Ohio State University Wexner Medical Center, Health, Stroke center, Lawyer, Education, Life, Physician, Patient, Faculty, Ohio State University, Everyday Health, Research, Doctor of Philosophy, Medicine, Management, Pharmaceutical industry, MD

NEW YORK, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Castle Connolly today announced the release of Castle Connolly Top Doctors 2023 .

Key Points: 
  • NEW YORK, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Castle Connolly today announced the release of Castle Connolly Top Doctors 2023 .
  • This year marks the 30th anniversary of Castle Connolly Top Doctors.
  • All Castle Connolly Top Doctors are nominated by their peers, and then the Castle Connolly research team evaluates important criteria to determine who makes the list, including professional qualifications, education, hospital and faculty appointments, research leadership, professional reputation, disciplinary history, interpersonal skills and outcomes data (where available).
  • To this end, Castle Connolly will launch new Top Doctor recognitions in 2023, including:

Male Plus Naturally Combats the Effects of Alcohol on the Libido

Retrieved on: 
Monday, January 23, 2023
Libido, Tribulus terrestris, Health, Testosterone, Healthline, Everyday Health, Male, Friends, Penis, Nightclub, Liquor

FORT LAUDERDALE, FL, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Tim Torfs, the creator of the natural male libido-enhancing product Male Plus, is aware of how important alcohol is for many people’s social lives.

Key Points: 
  • FORT LAUDERDALE, FL, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Tim Torfs, the creator of the natural male libido-enhancing product Male Plus, is aware of how important alcohol is for many people’s social lives.
  • At the same time, he knows how much heavy drinking can mess with a person’s ability to be intimate.
  • Torf’s Male Plus formula is an ideal way to combat the effects of too much alcohol for those in search of a simple, natural solution.
  • The supplement utilizes 100% natural active ingredients, including well-known libido enhancers like Tribulus Terrestris, maca root, and Siberian ginseng.

As Pandemic Recedes, Moms Report Feeling More Pressure Rather Than Less, According to Research From Everyday Health Group Pregnancy & Parenting

Retrieved on: 
Thursday, October 13, 2022
Content Marketing, Women, Parenting, Baby, Maternity, Marketing, Advertising, Communications, Digital Marketing, Consumer, Pressure, Parenting, Physician, Woman, Education, Family, Parent, NASDAQ, Human, Research, ZD, EHG, Generation Z, BabyCenter, Health, Behavior, Gen, Trauma, Generation X, Everyday Health, Ageing, Anxiety, Child, Pregnancy, COVID-19, Coffee, Pharmaceutical industry, Birth control, Millennials

Everyday Health Group Pregnancy & Parenting (EHG P&P), a division of the Everyday Health Group and home to BabyCenter and What to Expect today released its Motherhood Matrix Study, revealing that moms are currently experiencing deep-seated pressures and anxiety.

Key Points: 
  • Everyday Health Group Pregnancy & Parenting (EHG P&P), a division of the Everyday Health Group and home to BabyCenter and What to Expect today released its Motherhood Matrix Study, revealing that moms are currently experiencing deep-seated pressures and anxiety.
  • Gen Z moms are most likely to say they are wrestling with anxiety (79%), and nearly half (45%) report moderate to severe anxiety.
  • Everyday Health Group Pregnancy & Parenting (EHG P&P), a division of Everyday Health Group, is home to BabyCenter and What to Expect , the worlds most iconic and trusted pregnancy and parenting brands.
  • We empower healthcare providers and consumers with trusted content and services delivered through Everyday Health Groups world-class brands.